The triple jeopardy conundrum

The multiple investigations into bribery allegations surrounding UK-based pharmaceutical company GlaxoSmithKline raise questions as to whether double jeopardy principles might scupper countries’ enforcement efforts.

Get unlimited access to all Global Investigations Review content